Antidepressant Market 2020 | Complete Analysis by Experts with Industry Size & Growth, Industry Share, Latest Achievements Forecast till 2024

  • Sun Pharmaceuticals Pvt Ltd

    For More Information or Query or Customization Before Buying, Visit at

    Key Market Trends:

    Major Depressive Disorder Segment by Depressive Disorder is Expected to Account for the Largest Market Share During the Forecast Period

    The major depressive disorder possible causes comprise of the combination of biological, psychological, and social sources of distress. The major risk factors include family history, significant life changes, certain medications, chronic health problems, and substance abuse. As per the data published by the National Institute of Mental Health, an estimated 16.2 million adults in the United States had at least one major depressive episode. This number represented 6.7% of all US adults and is majorly prevalent in women as compared to men. Most commonly, selective serotonin reuptake inhibitors (SSRI) are used in the treatment of major depression, while there are some therapies available to normalize brain changes associated with depression. Thus, owing to the rising number of the patient pool, the market is expected to witness high growth over the forecast period.

    North America accounted for the Largest Share in the Global Market

    The increasing cases of depression is one of the major factors that is expected to drive the overall growth of the US antidepressant market over the forecast period. Moreover, there is a rise in the geriatric population in the United States, which is expected to create more opportunities for market players in the region. Women are twice as likely to be affected by generalized anxiety disorder (GAD) when compared to men. Six million adults, or 2.7% of the US population suffer from panic disorders, and around 2.2 million or 1.0% of the US population suffer from obsessive-compulsive disorder (OCD), which is found to be equally common among men and women. The two major factors leading to the rise in the consumption of antidepressants are the course of the treatment lasting longer than it used to be, and the antidepressants that are currently being prescribed are not only for severe depression, but also for mild depression, anxiety, social phobia, and more. The increasing prevalence of disorders and increasing rate of consumption of antidepressants are expected to drive the market studied during the forecast period.

    Purchase this Report (Price 4250 USD for single-user license) –

    Detailed TOC of Antidepressant Market Report 2020-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Cases of Depression
    4.2.2 Increasing Awareness about Depression
    4.2.3 Emergence of Novel Biologics
    4.3 Market Restraints
    4.3.1 Preference of Non-pharmacological Therapies over Pharmacological Therapies
    4.3.2 Side-effects and Patent Expiry of Antidepressant Drugs
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Product
    5.1.1 Selective Serotonin Reuptake Inhibitor (SSRI)
    5.1.2 Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
    5.1.3 Tricyclic Antidepressant (TCA)
    5.1.4 Monoamine Oxidase Inhibitor (MAOI)
    5.1.5 Other Products
    5.2 By Depressive Disorder
    5.2.1 Major Depressive Disorder
    5.2.2 Obsessive-compulsive Disorder (OCD)
    5.2.3 Generalized Anxiety Disorder (GAD)
    5.2.4 Panic Disorder (PD)
    5.2.5 Other Depressive Disorders
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East Africa GCC South Africa Rest of Middle East Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Allergan PLC
    6.1.2 AstraZeneca
    6.1.3 Eli Lilly and Company
    6.1.4 GlaxoSmithKline PLC
    6.1.5 H. Lundbeck AS
    6.1.6 Johnson Johnson
    6.1.7 Merck Co. Inc.
    6.1.8 Pfizer Inc.
    6.1.9 Sanofi
    6.1.10 Sun Pharmaceuticals Pvt Ltd


    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Exterior Structural Glazing Market Share 2020: Global Industry Outlook by Growth Segments, Types, Applications, and End-User Analysis Industry Size, Forecast to 2026

    Small-Scale Liquefaction Market Size, Share and CAGR Status 2020 – Global Industry Data by Top Manufacturers, Business Boosting Strategies, Upcoming Trends, Emerging Growth Factors till 2026

    Methyl Orthoformate Market Size, Share and CAGR Status 2020 – Global Industry Data by Top Manufacturers, Business Boosting Strategies, Upcoming Trends, Emerging Growth Factors till 2026

    Global Mobile Online Ticketing Market Size Report 2020 Market Dynamics and Developments, Industry Research Report by Top Manufactures, Types, Applications Forecast to 2026

    Land Seismic Equipment Market Future Trends, Growth Factors 2020: Global Opportunities by Leading Countries, Manufacturing Size and Share, Industry Segments by Types and Applications Forecast to 2026

    Corrosion Resistant Coatings and Paints Market Share and Forecast by 2020 to 2026 | Top Key Players Analysis Covers Regions with Growth Value, Comprehensive Development Strategy, Global Size with Revenue and COVID-19 Impact